Dianthus Therapeutics Inc.
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 12.2 | 151.0 | 16.7 | 238.8 | 215.3 | 174.8 | 122.5 | 99.3 | 137.3 | 483.8 | 764.8 | 3,016.4 | 2,869.1 | |
| – | – | – | – | – | 2.7 | 2.5 | 1.3 | 4.1 | 3.0 | 2.5 | 4.2 | 2.0 | 1.7 | 2.1 | 2.6 | 4.4 | 2.6 | 2.3 | 1.5 | 1.1 | 0.5 | 0.7 | 0.3 | 0.6 | 0.6 | 3.0 | 0.3 | 2.1 | 2.5 | 2.8 | 2.2 | 2.0 | 2.2 | 2.7 | 3.2 | 3.4 | 4.7 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 106.8 | -30.0 | 136.7 | 139.1 | 168.6 | 118.9 | 97.8 | 134.6 | 465.7 | 739.9 | 2,546.9 | 2,811.3 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 2,908.1 | – | – | |
| – | – | – | – | – | -7.4% | -10.4% | -26.2% | -10.2% | -11.5% | -15.3% | -10.1% | -24.5% | -21.5% | -20.2% | -17.0% | -11.2% | -11.1% | -13.8% | -23.5% | -37.4% | -95.9% | -43.4% | -120.4% | -41.2% | -16.3% | -4.2% | -53.6% | -3.9% | -4.5% | -6.7% | -10.3% | -14.0% | -15.1% | -7.4% | -8.3% | -3.2% | -2.9% | |
| Margins | ||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 96.5% | 95.7% | 96.4% | 96.8% | 99.5% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 94.3% | 96.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -1,012.5% | -1,295.5% | -1,704.7% | -1,809.4% | -1,669.8% | -1,545.0% | -1,633.7% | -1,796.4% | -2,676.6% | -4,558.4% | -8,739.3% | -14,318.0% | -11,441.4% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -952.5% | -1,216.4% | -1,541.2% | -1,557.5% | -1,376.4% | -1,250.3% | -1,362.8% | -1,544.0% | -2,364.1% | -4,104.8% | 0.0% | -847.5% | -1,570.9% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -198.0% | -628.9% | -894.3% | -928.9% | -965.0% | -1,168.0% | -1,255.6% | -1,394.3% | -2,067.6% | -3,561.6% | -6,349.4% | -9,766.8% | -8,178.0% | |
| Returns | ||||||||||||||||||||||||||||||||||||||
| – | – | – | -70.5% | -103.1% | -23.1% | -30.6% | -39.5% | -45.7% | -36.3% | -43.5% | -54.4% | -65.3% | -47.9% | -50.5% | -52.1% | -56.1% | -34.6% | -36.9% | -41.2% | -50.7% | -56.7% | -54.3% | -78.9% | -54.6% | -48.4% | -24.2% | -25.8% | -13.5% | -15.8% | -19.9% | -24.1% | -30.7% | -37.9% | -23.1% | 0.0% | -0.9% | -2.6% | |
| – | – | – | -65.2% | -90.8% | -22.0% | -28.3% | -36.6% | -41.4% | -33.4% | -39.6% | -47.5% | -56.7% | -43.7% | -45.8% | -46.4% | -50.1% | -31.9% | -33.9% | -37.5% | -39.4% | -43.9% | -41.0% | -69.9% | -50.6% | -45.9% | -22.4% | -24.3% | -13.1% | -15.4% | -18.9% | -22.7% | -28.9% | -35.2% | -21.9% | 0.0% | -0.9% | -2.5% | |
| Balance Sheet & Debt | ||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -69 | -51 | -55 | -15 | – | – | -157 | -132 | -329 | -314 | -33 | -22 | -9.9 | -13 | -56 | -51 | -627 | -110 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -97.9 | – | – | |
| – | – | – | 92.4% | 88.1% | 95.3% | 92.5% | 92.6% | 90.7% | 91.9% | 91.1% | 87.4% | 86.8% | 91.2% | 90.8% | 89.0% | 89.2% | 92.1% | 92.0% | 90.9% | 77.8% | 77.5% | 75.6% | 88.6% | 92.8% | 94.9% | 92.7% | 94.1% | 97.4% | 97.1% | 95.4% | 94.2% | 94.3% | 92.9% | 94.6% | 92.9% | 96.3% | 96.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.0 | 0.0 | 0.0 | 0.0 | – | – | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Per Share | ||||||||||||||||||||||||||||||||||||||
| – | – | – | -16.51 | -18.93 | -18.61 | -23.70 | -27.71 | -29.29 | -28.47 | -28.93 | -31.44 | -33.31 | -33.65 | -26.53 | -24.70 | -23.86 | -20.93 | -19.12 | -19.36 | -20.84 | -20.93 | -18.17 | -15.34 | -11.15 | -9.53 | -1.10 | -9.61 | -1.96 | -1.66 | -1.96 | -2.43 | -2.81 | -3.20 | -3.34 | 0.00 | -0.24 | -0.53 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.00 | 0.09 | 0.62 | 0.13 | 0.12 | 0.16 | 0.18 | 0.18 | 0.14 | 0.08 | 0.05 | 0.03 | 0.03 | |
| – | – | – | 23.41 | 18.36 | 80.61 | 77.48 | 70.18 | 64.15 | 78.36 | 66.57 | 57.82 | 50.97 | 70.25 | 52.58 | 47.44 | 42.52 | 60.45 | 51.81 | 47.00 | 41.14 | 36.91 | 33.48 | 19.43 | 20.44 | 19.68 | 4.57 | 37.28 | 14.52 | 10.47 | 9.87 | 10.06 | 9.18 | 8.46 | 14.46 | 13.05 | 25.01 | 20.92 | |
| – | – | – | -11.38 | -13.40 | -15.88 | -19.94 | -23.88 | -26.80 | -27.21 | -25.29 | -24.64 | -24.70 | -25.79 | -21.97 | -21.24 | -21.22 | -17.36 | -16.12 | -16.55 | -17.36 | -18.40 | -9.73 | -7.71 | -5.21 | -1.98 | -0.57 | -5.58 | -1.17 | -1.16 | -1.83 | -2.23 | -2.54 | -2.80 | -2.90 | -3.42 | -2.72 | -2.78 | |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.